Publicaciones en las que colabora con Julio César de la Torre Montero (5)

2013

  1. Circulating tumor cells following first chemotherapy cycle: An early and strong predictor of outcome in patients with metastatic breast cancer

    Oncologist, Vol. 18, Núm. 8, pp. 917-923

2012

  1. Glutathione S-transferase P1 c.313a > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients

    Annals of Oncology, Vol. 23, Núm. 7, pp. 1750-1756

2011

  1. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome

    Clinical Cancer Research, Vol. 17, Núm. 7, pp. 2006-2013

  2. Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

    Breast Cancer Research and Treatment, Vol. 128, Núm. 1, pp. 127-136

2009

  1. Circulating tumor cells in metastatic breast cancer: Timing of blood extraction for analysis

    Anticancer Research, Vol. 29, Núm. 10, pp. 4185-4187